| Financial Year |
March 31 2023 |
| Monetary Funds |
961,749,747.74 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,634,065.20 |
| Accounts Receivable |
1,419,781,684.45 |
| Advances to Suppliers |
98,195,137.41 |
| Other Receivables |
83,559,112.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
54,202,722.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
25,170,646.70 |
| Total Current Assets |
2,686,984,153.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
242,828,620.18 |
| Investment Properties |
142,592,378.15 |
| Fixed Assetes |
603,868,487.26 |
| Under-construction Projects |
226,677,605.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
200,545,014.26 |
| R&D expenses |
1,837,115.14 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
29,312,865.59 |
| Deferred Income Tax Assets |
74,419,615.54 |
| Other Non-Current Assets |
15,008,388.00 |
| Sub-Total of Non-Current Assets |
1,574,558,515.10 |
| Total Assets |
4,261,542,669.06 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
589,023,838.44 |
| Accounts Received In Advance |
4,482,118.36 |
| Employee Compensation Payable |
311,454,093.55 |
| Taxes Payable |
68,108,357.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
256,995,983.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,557,482.79 |
| Other Current Liabilities |
5,489,876.69 |
| Sub-Total of Current Liabilities |
1,355,573,273.68 |
| Long-term Loans |
52,191,723.07 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
383,457.28 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,892,151.88 |
| Deferred Income Tax Liabilities |
66,411,541.67 |
| Other Non-Current Liabilities |
61,656,948.62 |
| Sub-Total of Non-Current Liabilities |
217,617,975.99 |
| Total Liabilities |
1,573,191,249.67 |
| Paid-In Capital(Or Share Stock) |
380,095,146.00 |
| Capital Surplus |
1,059,336,378.08 |
| Surplus Reserve |
66,082,700.74 |
| LESS:Treasury Stock |
23,247,745.44 |
| Undistributed Profits |
1,188,348,972.86 |
| Minority Stockholder's Interest |
10,778,179.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,677,573,239.96 |
| Owner's Equity（Stockholder's Equity） |
2,688,351,419.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,261,542,669.06 |
